Top

Familial Cancer

Published in:

01-12-2010

Abstracts 3rd Biennial Meeting of InSiGHT (International Society for Gastrointestinal Hereditary Tumours)

Düsseldorf June 24–27 2009

Published in: Familial Cancer | Issue 4/2010

Title: Abstracts 3rd Biennial Meeting of InSiGHT (International Society for Gastrointestinal Hereditary Tumours)
Düsseldorf June 24–27 2009
Publication date: 01-12-2010
Publisher: Springer Netherlands
Published in: Familial Cancer / Issue 4/2010
Print ISSN: 1389-9600
Electronic ISSN: 1573-7292
DOI: https://doi.org/10.1007/s10689-010-9351-8

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras

Prof. Fabrice Barlesi

Developed by: Springer Medicine

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Please log in to get access to this content

Other articles of this Issue 4/2010

Magnetic resonance colonography for colorectal cancer screening in patients with Lynch syndrome gene mutation

Pancreatic cancer risk counselling and screening: impact on perceived risk and psychological functioning

Report of the Combined Meeting of the International Society for Gastrointestinal Hereditary Tumours, the Human Variome Project and the National Cancer Institute Colon Cancer Family Registry, Duesseldorf, Germany, 24 June 2009

Similarities in solar ultraviolet irradiance and other environmental factors may explain much of the family link between uveal melanoma and other cancers

BRCA1 mutations and colorectal cancer in Poland

Can a phenotype for recessive inheritance in breast cancer be defined?

Keynote webinar | Spotlight on antibody–drug conjugates in cancer